Literature DB >> 15277158

Antioxidant deficiency in cystic fibrosis: when is the right time to take action?

Evelyn I Back1, Claudia Frindt, Donatus Nohr, Juergen Frank, Rita Ziebach, Martin Stern, Michael Ranke, Hans K Biesalski.   

Abstract

BACKGROUND: Little is known about age- and disease-related changes in prooxidant and antioxidant systems in patients with cystic fibrosis (CF).
OBJECTIVE: We investigated changes in antioxidant concentrations and oxidative stress in plasma, buccal mucosal cells (BMCs), and breath condensate in patients with CF in relation to age and disease progression.
DESIGN: We recruited 22 patients with CF as well as 35 healthy control subjects and conducted a cross-sectional study by dividing the participants into 4 age groups (<6 y, 6-11 y, 12-17 y, > or =18 y). We collected fasting blood samples, BMCs, and breath condensate. Carotenoids, alpha-tocopherol, vitamin C, protein carbonyls, thiobarbituric acid-reactive substances, and F(2)alpha-isoprostane were assessed.
RESULTS: In patients with CF, plasma vitamin C concentrations, plasma and BMC alpha-tocopherol concentrations, and forced expiratory volume in 1 s (percentage predicted) decreased significantly with age. Plasma beta-carotene, beta-cryptoxanthin, and total lycopene were significantly lower in patients than in control subjects in all age groups. Furthermore, alpha-tocopherol and vitamin C plasma concentrations as well as alpha-tocopherol concentrations in BMCs were significantly lower in CF patients > or =18 y old, whereas all indicators of oxidative stress assessed were significantly higher than those same indicators in control subjects.
CONCLUSIONS: Adult patients with CF in particular showed distinct vitamin deficits and elevated indicators of oxidative stress in plasma, BMCs, and breath condensate along with a progression of clinical status. We suggest that early in life dietary habits should be improved and that innovative supplementation strategies should be applied to optimize the antioxidant status of patients with CF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277158     DOI: 10.1093/ajcn/80.2.374

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients.

Authors:  Konstantinos Papas; John Kalbfleisch; Ricky Mohon
Journal:  Dig Dis Sci       Date:  2007-01-10       Impact factor: 3.199

2.  Can changes in hydrophobicity increase the bioavailability of alpha-tocopherol?

Authors:  Evelyn I Back; Claudia Frindt; Erika Oćenásková; Donatus Nohr; Martin Stern; Hans K Biesalski
Journal:  Eur J Nutr       Date:  2005-03-22       Impact factor: 5.614

Review 3.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

4.  "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.

Authors:  S N Lavergne; H Wang; H E Callan; B K Park; D J Naisbitt
Journal:  J Pharmacol Exp Ther       Date:  2009-08-07       Impact factor: 4.030

Review 5.  Cystic fibrosis-related oxidative stress and intestinal lipid disorders.

Authors:  Marie-Laure Kleme; Emile Levy
Journal:  Antioxid Redox Signal       Date:  2015-01-22       Impact factor: 8.401

6.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

7.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

8.  Supplementation with red palm oil increases β-carotene and vitamin A blood levels in patients with cystic fibrosis.

Authors:  Olaf Sommerburg; Silke De Spirt; Annett Mattern; Cornelia Joachim; Claus-Dieter Langhans; Kalanithi Nesaretnam; Werner Siems; Wilhelm Stahl; Marcus A Mall
Journal:  Mediators Inflamm       Date:  2015-01-26       Impact factor: 4.711

9.  Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections.

Authors:  Izabela Sadowska-Bartosz; Sabina Galiniak; Grzegorz Bartosz; Marta Rachel
Journal:  Oxid Med Cell Longev       Date:  2014-04-03       Impact factor: 6.543

10.  Oral Supplementation with a Special Additive of Retinyl Palmitate and Alpha Tocopherol Reduces Growth Retardation in Young Pancreatic Duct Ligated Pigs Used as a Model for Children Suffering from Exocrine Pancreatic Insufficiency.

Authors:  Anne Mößeler; Marion Schmicke; Martin Höltershinken; Martin Beyerbach; Josef Kamphues
Journal:  Int J Mol Sci       Date:  2016-09-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.